We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Applying Deep Learning Architectures to de novo Molecular Drug Design
Video

Applying Deep Learning Architectures to de novo Molecular Drug Design

Applying Deep Learning Architectures to de novo Molecular Drug Design
Video

Applying Deep Learning Architectures to de novo Molecular Drug Design

Dr Ola Engkvist, AstraZeneca, outlines how deep learning architectures are being applied to drug discovery.

Advertisement